Abbott Laboratories (Pakistan) Ltd manufactures, imports, and markets research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Brufen, Surbex Z, Arinac, Glucerna, Pediasure, and Ensure.
1948
1.4K+
LTM Revenue n/a
LTM EBITDA n/a
$419M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Abbott Laboratories (Pakistan) has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Abbott Laboratories (Pakistan) achieved revenue of $199M and an EBITDA of $15.1M.
Abbott Laboratories (Pakistan) expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Abbott Laboratories (Pakistan) valuation multiples based on analyst estimatesFY 2022 | FY 2023 | FY 2024 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $177M | $199M | n/a | n/a | XXX |
Gross Profit | $57.8M | $52.2M | $42.6M | XXX | XXX |
Gross Margin | 33% | 26% | NaN% | XXX | XXX |
EBITDA | $27.4M | $15.1M | n/a | n/a | XXX |
EBITDA Margin | 15% | 8% | NaN% | NaN% | XXX |
Net Profit | $21.4M | $10.8M | $0.9M | XXX | XXX |
Net Margin | 12% | 5% | NaN% | XXX | XXX |
Net Debt | n/a | n/a | n/a | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of February 14, 2025, Abbott Laboratories (Pakistan)'s stock price is PKR 1230 (or $4).
Abbott Laboratories (Pakistan) has current market cap of PKR 120B (or $433M), and EV of PKR 117B (or $419M).
See Abbott Laboratories (Pakistan) trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$419M | $433M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of February 14, 2025, Abbott Laboratories (Pakistan) has market cap of $433M and EV of $419M.
Abbott Laboratories (Pakistan)'s trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Abbott Laboratories (Pakistan)'s 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Abbott Laboratories (Pakistan) and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $419M | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAbbott Laboratories (Pakistan)'s NTM/LTM revenue growth is n/a
Abbott Laboratories (Pakistan)'s revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $23K for the same period.
Over next 12 months, Abbott Laboratories (Pakistan)'s ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Abbott Laboratories (Pakistan)'s 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Abbott Laboratories (Pakistan) and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | n/a | XXX | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
Opex per Employee | $23K | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 8% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 0% | XXX | XXX | XXX | XXX |
Opex to Revenue | 17% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Abbott Laboratories (Pakistan) acquired XXX companies to date.
Last acquisition by Abbott Laboratories (Pakistan) was XXXXXXXX, XXXXX XXXXX XXXXXX . Abbott Laboratories (Pakistan) acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Abbott Laboratories (Pakistan) founded? | Abbott Laboratories (Pakistan) was founded in 1948. |
Where is Abbott Laboratories (Pakistan) headquartered? | Abbott Laboratories (Pakistan) is headquartered in Pakistan. |
How many employees does Abbott Laboratories (Pakistan) have? | As of today, Abbott Laboratories (Pakistan) has 1.4K+ employees. |
Is Abbott Laboratories (Pakistan) publicy listed? | Yes, Abbott Laboratories (Pakistan) is a public company listed on KAR. |
What is the stock symbol of Abbott Laboratories (Pakistan)? | Abbott Laboratories (Pakistan) trades under ABOT ticker. |
When did Abbott Laboratories (Pakistan) go public? | Abbott Laboratories (Pakistan) went public in 1982. |
Who are competitors of Abbott Laboratories (Pakistan)? | Similar companies to Abbott Laboratories (Pakistan) include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
What is the current market cap of Abbott Laboratories (Pakistan)? | Abbott Laboratories (Pakistan)'s current market cap is $433M |
Is Abbott Laboratories (Pakistan) profitable? | Yes, Abbott Laboratories (Pakistan) is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.